|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Cardinal Bernardin Cancer Center, Loyola University Chicago (Drs. Rizzo, Carbone, Fisher, Matker, Swinnen, Powers, Di Resta, Alkan, and Fisher), Maywood, IL; and Wayne State University, Harper Hospital (Dr. Pass), Detroit, MI.
Correspondence to: Michele Carbone, MD, PhD, Cardinal Bernardin Cancer Center, Room 205, 2160 South First Ave, Maywood, IL 60153; e-mail: mcarbon{at}orion.it.luc.edu
Simian virus 40 (SV40) causes mesotheliomas, osteosarcomas, ependymomas, choroid plexus tumors, and lymphomas in hamsters. In humans, SV40 has been detected in tumors of the first four types. Using the polymerase chain reaction (PCR), we tested 29 non-Hodgkins lymphomas (intermediate and high-grade), 25 posttransplant lymphoproliferative disorders, and 5 AIDS lymphomas for SV40 DNA. PCR analysis revealed that 3 of 29 lymphomas, 6 of 25 posttransplant lymphoproliferative disorders, and 2 of 5 AIDS lymphomas contained SV40 sequences corresponding to the retinoblastoma (RB)-pocket binding domain of SV40 tumor antigen (Tag). However, among positive samples, only one posttransplant lymphoproliferative disorder and one AIDS lymphoma contained the SV40 regulatory region, which suggest a higher viral load in these patients. In parallel experiments, 8 of 12 mesotheliomas tested positive for SV40 for both the RB-pocket binding domain of Tag and the SV40 regulatory region. These data confirm the presence of SV40 in most United States mesotheliomas and indicate that in human non-Hodgkins lymphomas, the prevalence of SV40 is low.
This article has been cited by other articles:
![]() |
D. L. Poulin and J. A. DeCaprio Is There a Role for SV40 in Human Cancer? J. Clin. Oncol., September 10, 2006; 24(26): 4356 - 4365. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Engels, R. P. Viscidi, D. A. Galloway, J. J. Carter, J. R. Cerhan, S. Davis, W. Cozen, R. K. Severson, S. de Sanjose, J. S. Colt, et al. Case-Control Study of Simian Virus 40 and Non-Hodgkin Lymphoma in the United States J Natl Cancer Inst, September 15, 2004; 96(18): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Vilchez and J. S. Butel Emergent Human Pathogen Simian Virus 40 and Its Role in Cancer Clin. Microbiol. Rev., July 1, 2004; 17(3): 495 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Nakatsuka, A. Liu, Z. Dong, S. Nomura, T. Takakuwa, H. Miyazato, and K. Aozasa Simian Virus 40 Sequences in Malignant Lymphomas in Japan Cancer Res., November 15, 2003; 63(22): 7606 - 7608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. MacKenzie, K. S. Wilson, J. Perry, A. Gallagher, and R. F. Jarrett Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom J Natl Cancer Inst, July 2, 2003; 95(13): 1001 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Strickler, J. J. Goedert, S. S. Devesa, J. Lahey, J. F. Fraumeni Jr., and P. S. Rosenberg Trends in U.S. Pleural Mesothelioma Incidence Rates Following Simian Virus 40 Contamination of Early Poliovirus Vaccines J Natl Cancer Inst, January 1, 2003; 95(1): 38 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. TOGNON, F. MARTINI, L. IACCHERI, R. CULTRERA, and C. CONTINI Investigation of the simian polyomavirus SV40 as a potential causative agent of human neurological disorders in AIDS patients J. Med. Microbiol., February 1, 2001; 50(2): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |